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Introduction
Through a number of methodological advances, arterial spin labeling (ASL) perfusion MRI has reached a level that allows its application in multiple clinical and research applications for the visualization and quantification of cerebral blood flow (CBF) 1, 2 . Since ASL is non-invasive and offers absolute CBF quantification, it is an attractive tool compared to alternative perfusion modalities 3, 4 . Furthermore, quantitative ASL CBF maps are reproducible and comparable with perfusion measurements from the "gold standard" H 2 O
15
-PET [5] [6] [7] . Implementations of ASL are commercially available on all major MRI systems and the number of clinical applications is continuously growing. Measurements of regional CBF promise clinical value in a variety of common neurological disorders, such as cerebrovascular disease, epilepsy, neurodegeneration and brain tumors, and ASL is recognized as a particularly valuable research tool for cognitive and pharmacological neuroscience 8, 9 .
One obstacle that impedes standardized clinical and research applications of ASL, is the substantial differences in the commercial implementations of ASL from the major MRI vendors 10 . A variety of possible labeling and readout strategies exists, and each vendor has implemented a different combination of labeling and readout strategies for their commercial ASL release 10 . General Electric (GE) Healthcare offers pseudo-continuous ASL (PCASL) with a segmented 3D spiral fast spin-echo (FSE) readout, Philips Healthcare has PCASL paired with a single-shot 2D echo-planar imaging (EPI) readout and
Siemens Healthcare provides pulsed ASL (PASL) combined with a segmented 3D gradient and spinecho (GRASE) readout [11] [12] [13] .
These labeling and readout differences between product sequences produce qualitatively different perfusion-weighted images, which can be visually appreciated on a single-subject level as shown in
Figure 1a 14, 15 . On a group level, it is currently not possible to compare CBF-values from a single region of interest (ROI) in a multi-center study, mainly because of differences in readout between sequences from different vendors 16, 17 . Global CBF-values, however, show quantitative agreement between vendors 16 . Furthermore, the inter-vendor global CBF inter-session variation is comparable to the intra-vendor global CBF variation 15, 16 . These observations support the possibility of future multi-center ASL research, if all vendors could implement an identical ASL sequence.
The current study aims to assess multi-vendor ASL CBF variations using a near-identical sequence across vendors, with the same labeling and readout approach. PCASL was selected as a labeling strategy, because of its wide compatibility with all platforms and superior labeling efficiency for single time-point CBF measurements 10, 15, 18 . A multi-slice single-shot 2D EPI readout was selected because of its availability on all systems and as it has been used in the majority of previous ASL studies 10 . Because of differences in gradient and RF coil specifications between two vendor systems available for our study, two 2D echo-planar imaging (EPI) PCASL sequences were used with slightly different labeling and readout parameters. These will be referred to as study 1 and 2. For one vendor system, both variants of our sequence could be implemented, enabling an additional intra-vendor comparison of these slightly different sequences. Figure 1 . a) Perfusion-weighted maps from a single subject scanned with product sequences from GE (PCASL with a 3D spiral FSE readout), Philips (PCASL with a 2D EPI readout) and Siemens (PASL with a 3D GRASE readout). Sequence parameters included PLD=1525 ms, 4 time points, true axial (GE), PLD=1525 ms (Philips) and TI=2300 ms, TI1=80 ms, 4 time points (Siemens). b) Perfusionweighted maps from a single representative subject scanned with the sequence used in the current study (parameters shown in Table 1 and 2). All perfusion weighted maps were scaled to have a mean gray matter cerebral blood flow of 60 mL/100g/min, linearly registered, re-sliced and skull-stripped.
Multi-vendor reliability of ASL perfusion MRI using a near-identical sequence Table 2 . Different labeling and readout parameters. PLD = post-label delay; TE = echo time; TR = readout time
Materials and Methods

MRI scanners
Three 3T MRI scanners were used in this single-center multi-vendor comparison: GE Signa HDxt (2006, 60 cm bore opening, General Electric Healthcare, Milwaukee, WI, US), Philips Achieva (2007, 60 cm bore opening, Philips Healthcare, Best, the Netherlands) and Siemens Skyra (2011, 70 cm bore opening, Siemens Healthcare, Erlangen, Germany). None of the vendors were involved in designing or conducting this study, none had access to the data, and none were involved in data analysis or preparation of this manuscript. Because the main purpose of the study was to compare the inter-and intra-vendor reproducibility, without addressing the performance of each vendor system explicitly, vendor and coil names were anonymized by pseudo-randomly reordering the vendor names into vendor A, B and C. Vendor A was included in both studies because its gradient and RF coil specifications allowed sequence implementation identical to both vendor B and C. The scanners of vendor A and B
were equipped with 8-channel head coils, whereas the scanner of vendor C was equipped with a 20-channel head-neck coil. Vendor A and C were separated by a five-minute walk, whereas vendor B was located at 20 minutes traveling distance by public transport from the location of the two other scanners.
Study design
Fourteen healthy volunteers (50% male, mean age 26.4 ± 4.7 (SD) years) were included, of which 11 (5 men, mean age 25.2 ± 4.5 years) were included in study 1 and all 14 subjects were included in study 2.
Both the local regional ethics committee and the local University Hospital internal ethical review board approved the study and all subjects provided written informed consent. In addition to standard MRI exclusion criteria, subjects with history of brain or psychiatric disease or use of medication -except for oral contraceptives -were excluded. To minimize physiological perfusion fluctuation, physical exercise and consumption of alcohol or recreational drugs was prohibited for 24 hours prior to scanning, except for caffeine or nicotine, which were restricted for 6 hours before the scanning sessions 19 . In both studies, each participant was scanned twice on two different scanners (i.e. four MRI examinations per participant per study) within three hours, to limit the effect of physiological perfusion fluctuations 
Acquisition
Each scan session included a balanced PCASL sequence with a single-shot gradient-echo EPI readout and a 1 mm isotropic 3D T1-weighted structural scan for segmentation and registration purposes.
Detailed similarities and differences between the PCASL protocols are summarized in Tables 1 and 2 .
The field-of-view was positioned parallel to the anterior-posterior commissure (ACPC) line. Due to restrictions imposed by two of the MR systems the labeling plane was fixed parallel to the stack of imaging slices. analyses. Motion parameters were estimated and did not differ between vendors (p>0.1 for both studies, paired t-test). To avoid confounding effects from motion correction due to possible signal-to-noise ratio (SNR) differences between vendors or coils, no motion correction was applied. The first five control and label pairs were discarded to avoid any non-steady state effects in the MRI signal. The remaining control (M control ) and label (M label ) images were pair-wise subtracted and averaged. The average control image was used to derive M0, by assuming a fixed single T1 of tissue (equal to T1 GM described below). These perfusion-weighted images were quantified into CBF maps using a single compartment model 10 :
Post-processing: quantification
where λ is the brain-blood partition coefficient (0.9 mL/g) , PLD is the post-label delay of each slice (Table 2) ; T 1a is the longitudinal relaxation time of arterial blood (1650 ms), α is the labeling efficiency (85%) and τ is the label duration ( Table 2) 11, 20, 21 . 1 − (− / 1 ) corrects for the incomplete signal recovery of the control images; TR is the repetition time (Table 2 ) and T1 GM is the longitudinal relaxation time of GM (1240 ms). The same quantification parameters were used for GM and white matter (WM).
Post-processing: spatial normalization
A single 3D T1-weighted anatomical scan for each subject (n=14) was segmented into GM and WM tissue probability maps. To avoid registration effects from differences in the T1-weighted reference images, the T1-weighted images from a single vendor (vendor A) were used. All CBF maps were transformed into anatomical space by a rigid-body registration of the average control image to the skullstripped T1-weighted scan. To spatially normalize both anatomical differences between subjects and residual EPI geometric distortion differences between vendors, a three-stage normalization strategy was applied, based on DARTEL (Diffeomorphic Anatomical Registration analysis using Exponentiated Lie algebra) 22 . First, a T1-based DARTEL template was created using the GM and WM probability maps from the T1-weighted scans. The resulting DARTEL flow fields were applied to the average control images of all vendors, removing anatomical differences between subjects. Afterwards, the normalized mean EPI control images were segmented into GM and WM probability maps from which vendorspecific EPI-based DARTEL templates were created. The resulting flow fields were applied to the mean control images, removing residual geometric differences between subjects 23 . Finally, the vendor-specific EPI-based DARTEL templates were warped to the T1-based DARTEL template, removing geometric distortion differences between vendors. All transformations were applied to the corresponding CBF maps.
Data analysis
Reproducibility was evaluated by means of quantitative CBF agreement and inter-session variation, testing whether the mean CBF is equal for different vendors and whether the inter-vendor inter-session variation is equal to the intra-vendor variation. These hypotheses were tested quantitatively on both a region of interest (ROI) and on a voxel level. In addition, a qualitative similarity comparison of the major features of the CBF maps was performed by three neuro-radiologists.
All intra-vendor reproducibility analyses were based on a comparison of session 1 with session 2 within each vendor (n=11 and n=14 for study 1 and 2 respectively, colored arrows in Figure 2 ). All intervendor reproducibility analyses were based on pooled comparisons of both the first sessions between vendors and the second sessions between vendors (n=22 and n=28 for study 1 and 2 respectively, black arrows in Figure 2 ). To compare both studies, the results from vendor A will be used because of its participation in both studies (first 11 subjects only). All reproducibility analyses were based on the mean CBF of the compared sessions and on the standard deviation of the paired inter-session CBF difference (SDΔCBF). The within-subject coefficient of variation (wsCV) -a normalized parameter of inter-session variation -was defined as the ratio of SDΔCBF to the mean CBF of both compared sessions
Data analysis: ROI definition
Subject-specific total cerebral GM and deep cerebral WM masks were obtained by thresholding GM and WM probability maps at 80% and 99% tissue probabilities respectively. WM masks were threefold eroded to avoid GM contamination 25 . ROIs of anterior, middle and posterior flow territories (supplied by the anterior, middle and posterior cerebral artery respectively) were created from standard vascular territory templates 26 and ROIs associated with age-related dementia (anterior and posterior cingulate, precuneus) were created from the Wake Forest University Pick-atlas (http://fmri.wfubmc.edu/cms/software). All standard ROIs were masked with the subject-specific GM masks. Since almost all distributions deviated from normal -according to the Shapiro-Wilk test -the median was used to summarize CBF within a ROI.
Data analysis: voxel-based comparison
To assess reproducibility differences spatially, CBF-and wsCV-values were computed for each voxel. In order to visualize how much larger or smaller the inter-vendor SD∆CBF was than the intra-vendor SD∆CBF, a voxel-wise variation ratio map was created according to the following equation 27 :
This map was created for each study, including the two inter-and the two intra-vendor inter-session comparisons (black and colored arrows respectively in Figure 2 ). If the inter-vendor covariance is equal to the intra-vendor covariance, we expect a mean variation ratio of 100%. Individual GM CBF histograms (80 bins, range -10-110 mL/100g/min) were averaged to generate a group-level histogram.
GM wsCV (80 bins, range 0-100%) and ratio (80 bins, range 20-180%) histograms were generated.
Both on an ROI and on a voxel level, mean CBF differences between vendors were tested for significance using a paired two-tailed Student's t-test. The Levene's test was used to test whether the inter-vendor inter-session SD∆CBF was significantly different from the intra-vendor inter-session SD∆CBF.
Data analysis: qualitative similarity index
In order to compare the inter-and intra-vendor reliability qualitatively, inter-and intra-vendor head-tohead CBF maps were rated for their similarity by three neuroradiologists (FBP, SF and JH) with at least five years of experience with ASL. The following comparisons were included: intra-vendor comparisons (colored arrows Figure 2 ) for vendor A and B (n=2*11) and vendor A and C (n=2*14) as well as intervendor comparisons (black arrows Figure 2 ) for vendor A vs. B sessions 1 and 2 (n=2*11) and vendor A vs. C sessions 1 and 2 (n=2*14), adding up to 100 comparisons in total. The 100 comparisons were pseudo-randomized and only the skull-stripped, spatially normalized cerebrum was included, to avoid any recognizable vendor-specific geometric distortion or susceptibility artifacts. The spatially normalized CBF maps were divided into 20 slices and rescaled slice-wise, such that the mean GM CBF of each slice was equal for the compared sessions. All comparisons were converted into color-scaled DICOM images containing the two compared sessions per image, horizontally side by side.
After giving a first general impression for the total GM, the raters provided an ordinal score from 1 to 5
for the anterior, middle and posterior flow territories and for the deep GM consecutively, based on similarity of morphology and intensity. Similarity scores were defined as 1) poor, 2) fair, 3) moderate, 4) good and 5) excellent. Krippendorff's alpha was used to quantify the inter-rater agreement. The mean rating of all three neuroradiologists was used for analysis. Intra-and inter-vendor similarity scale histograms (5 bins, range 1-5) were generated for the abovementioned ROIs. A two-sample t-test was used to test whether the inter-vendor similarity was lower than the intra-vendor similarity. Significance was thresholded at p=0.05 in all analyses.
Results
Session timing
The intra-vendor inter-session time intervals did not differ between vendors in study 1 (p=0.6, paired ttest) or study 2 (p=0.3), but were 31 min longer for vendor A study 1 than for vendor A study 2 (p<0.01, Figure 2 ). The ASL scans of study 1 (18h50 ± 2h00) were performed 2h20 later on each day (p<0.01) than those of study 2 (16h30 ± 3h20). Study 1 was performed 2.7 weeks after study 2 (p<0.01).
Region-based comparison
Both the ROI-based median CBF-values (Table 3 ) and paired inter-session differences (summarized by wsCV in Table 4 ) were normally distributed. For all ROIs the mean CBF did not differ significantly between vendor A and B in study 1 (p>0.1). The mean regional CBF of vendor A was 2-19% higher (p<0.01 in most ROIs) than the mean regional CBF of vendor C in study 2, with the largest differences in the posterior flow territory and in the posterior cingulate gyrus. In addition, CBF values of vendor A in study 1 were 10-22% lower (p<0.01 in most ROIs) than those of the same vendor in study 2. Except for the posterior cingulate cortex in study 1 (p<0.01), there were no differences between the intra-and inter-vendor SDΔCBF of study 1 (p>0.1) or of 2 (p>0.2). However, the SDΔCBF of vendor A was 1.5-2 times as large for the sequence in study 1 as compared to the sequence in study 2, which was significant for the anterior (p=0.04) and posterior flow territory (p=0.04) and precuneus (p=0.03).
Voxel-based comparison
The CBF maps of a single representative subject show that visually the cortical and subcortical GM-WM differentiation was more comparable between vendors with the near-identical sequences ( Figure 1b ) than with product sequences (Figure 1a) . The group mean CBF maps ( Figure 3 ) of vendor A and B (study 1) appeared very similar visually, with slight differences in the inferior part of the cerebellum and in the orbito-frontal lobe. This was also reflected by the similarly appearing histograms. However, the mean CBF maps of vendor A and C (study 2) showed significant intensity differences, most notably in the posterior flow territory and in the cerebellum. The histograms of vendors A and C have an identical appearance, except for a shift of the peak location for vendor A to higher CBF as compared to vendor C. Interestingly, the largest difference was observed when the results of the same vendor (A) were compared between the sequences of study 1 and 2 ( Figure 5a ). The mean CBF and CBF distributions on histograms were lower and wider in study 1 compared to study 2 and for most voxels on the parametric maps the CBF-values were larger for study 2 than for study 1.
In both studies, the wsCV maps and histograms ( Figure 4 ) appeared similar between vendors, with only slightly larger variation for vendor A compared to vendor B (study 1) throughout the brain and for vendor C compared to vendor A (study 2) in the posterior flow territory. Areas of largest variation were the deep GM, posterior flow territory (including the cerebellum) and the orbito-frontal cortex. The intervendor wsCV maps showed the same spatial distribution as the intra-vendor maps, but the overall wsCV was somewhat higher. Likewise, the inter-and intra-vendor wsCV histograms appeared similar, but the inter-vendor wsCV distribution was shifted towards higher values. Interestingly, the wsCV histograms of vendor A in study 1 were higher and wider than the histograms of the same vendor in study 2. The values on the wsCV maps of vendor A study 2 visually appeared lower and more homogeneous compared to vendor A study 1, which was shown to be significant in the majority of the voxels ( Figure   5b ).
The inter-to intra-vendor variation ratio ( Figure 6 ) was heterogeneously distributed and ranged from 75 -125 % in the majority of voxels. Based on the histograms, the mean ratio was slightly higher than 100%
and the distribution was approximately Gaussian, with slightly more voxels having a higher inter-than intra-vendor SDΔCBF. There were a few voxels with significantly higher inter-than intra-vendor SDΔCBF, which were mainly situated in the posterior flow territory for vendor A vs. B and spread throughout the brain for vendor A vs. C. Figure 5 . Binary parametric maps projected on mean gray matter (GM) probability maps: a) voxel-wise significant CBF differences between study 1 and 2 (p<0.05). There were no voxels for which the mean CBF of study 1 was significantly larger than the mean CBF of study 2. b) voxel-wise significant differences in standard deviation of the paired inter-session CBF difference (SDΔCBF) (p<0.05).
Similarity scale
The inter-rater agreement of the visual similarity scale was moderate (Krippendorff's α=0.44-0.57) in most ROIs, but only fair in the deep GM (α=0.28). There was no substantial inter-rater agreement difference between the intra-vendor (Krippendorff's α=0.27-0.48) and inter-vendor (α=0.26-0.62) comparisons.
For both the intra-and inter-vendor similarity, the average rate ranged from fair to good, and was 'moderate' in most ROIs (Figure 7) . In study 1, the inter-vendor similarity (2.7 ± 0.2) was on average 10.8 ± 2.3% lower than the intra-vendor similarity (3.0 ± 0.2). In study 2, the inter-vendor similarity (3.4 ± 0.3) was on average 8.8 ± 4.8% lower than the intra-vendor similarity (3.8 ± 0.2), which was significant for the total GM, posterior flow territory and deep GM. Whereas the similarity scale histograms of the total GM, anterior and middle flow territories had similar means, the deep GM histogram was somewhat lower and the posterior flow territory histograms had the lowest mean. All histograms of study 2 had a smaller distribution and higher mean than the histograms of study 1 (p<0.01).
Discussion
Using near-identical PCASL sequences, we were able to acquire similar CBF images on 3T systems from the three major MRI vendors. The main results of this study are threefold. First, there were no significant CBF differences between vendors within study 1, but there was a significant difference between vendors within study 2 as well as a significant difference in CBF obtained with the sequence of study 1 versus the sequence of study 2 within the same vendor. Second, the inter-vendor inter-session variation was larger than the intra-vendor variation, although this did not reach significance in most ROIs or voxels. Finally, for the qualitative expert ratings, the inter-vendor similarity was 9-11% lower than the intra-vendor similarity, but the inter-vendor similarity was still 'moderate'. These results indicate that it may be possible to pool multi-vendor ASL results obtained with near-identical sequences, but also that minor residual sequence differences can have a large effect on the reliability of ASL.
The general appearance of the CBF and wsCV-maps obtained from the current work is in agreement with what can be expected from PCASL with a 2D gradient-echo EPI readout: excellent GM-WM contrast, heterogeneously appearing GM CBF and wsCV with vascular CBF peaks and lower CBF and higher wsCV in regions sensitive to susceptibility induced artifacts such as the orbito-frontal and inferior temporal cortices 16, 28 . The visual similarity of these CBF-and wsCV-maps is substantially higher than that shown in previous multi-vendor ASL comparisons, in particular one in which a different readout (2D EPI vs. 3D spiral) was employed 16 . The largest difference between vendors in that study was the difference in spatial blurring between the readouts and reconstruction as used by both vendors, which was reflected in the GM-WM CBF contrast. Whereas the GM-WM CBF ratio differed by a factor 2 between 2D and 3D readouts, this ratio was very consistent in the present results, ranging from 3.5 -3.9
for all vendors 14, 16, 17 . This indicates that if a similar readout and reconstruction is used, ASL results are comparable between vendors, despite residual hardware differences such as differences in gradient or coil specifications. Since differences in spatial correlation can seriously affect the ability of ASL to detect regional CBF differences, these results provide a strong argument for the importance of using the same ASL readout in multi-center studies.
To our surprise the mean and inter-session variation of CBF differed more for the same vendor across the two studies than between different vendors within the same study, both in the quantitative and qualitative analysis. These results strongly suggest that even minor sequence changes can result in a significant effect on the mean and inter-session variation of CBF. Moreover, this indicates that small differences in sequence parameters have a larger effect on the reproducibility of ASL than hardware or software differences between vendors, even when the same labeling and readout strategies are used.
Future multi-center perfusion studies should therefore not only focus on keeping ASL sequence parameters as equal as possible between centers, but also within a center (i.e. no software updates or upgrades resulting in small sequence changes).
One possible explanation for the mean CBF difference between studies could be the different slice readout times, leading to a mean effective PLD that is 100 ms longer for study 1 than for study 2. A longer PLD leads to more T1 decay, lower SNR and proportionally more spins in the tissue compartment than blood compartment -hence proportionally more faster decay with the T1 of tissue.
This results in a relative underestimation of CBF for study 1 compared to study 2. These PLD effects lead to an arrival time dependent relative CBF underestimation for study 1 compared to study 2, which is in agreement with our results. Furthermore, the larger T2* decay with longer TE in study 1 reduces SNR for both the ΔM and M 0 (control) image which can partly explain its larger variation compared to study 2, both in the wsCV-maps as well as in the qualitative similarity rating. Another effect of the differences in effective PLD is a different macro-vascular weighting between study 1 and study 2. The shorter effective PLD in study 2 compared to study 1 may have provided more macro-vascular weighting, which may overestimate CBF. Despite the variation differences between the studies, the interto intra-vendor inter-session variation ratio was very similar. The histogram showed only slightly more voxels where inter-vendor inter-session variation was larger than intra-vendor variation in study 1 compared to study 2. Again, these voxels seemed to be mainly found in the posterior region and cerebellum. This suggests that the abovementioned additional sources of variability for study 1 -such as larger T2* decay and larger PLD for study 1 -have a relatively similar contribution to both the intraand inter-vendor variability. Another difference between the sequences in both studies, was the interpulse time of the labeling RF train -a difference of approximately 150 μs. This is expected to have affected the labeling efficiency, although we do not expect that this had a significant effect on the wsCV 29 .
Whereas we observed very good agreement between the mean CBF values of vendor A and vendor B in study 1, there was a significant whole brain CBF difference between vendor A and vendor C in study 2.
The most likely cause of the larger CBF difference in study 2 is the different receiver coils used by the two vendors in this study (8 versus 20 channels); contrary to study 1 where both vendors had identical 8-channel head coils. A post-hoc quality assurance analysis (head phantom scanned with an IEC 2D spin echo sequence, data not shown) showed that the SNR of the scanners of vendor B and C were 71% and 155% relative to vendor A 30, 31 . However, the inter-session variation of vendor C was only lower than vendor A in the anterior orbito-frontal region and not in other areas of the brain. Perhaps, physiological variability already dominated most regions of the brain and additional SNR only helped in regions with lowest sensitivity, such as areas prone to susceptibility induced artifacts. Additional explanations could include differences in gradient specifications or shimming of the labeling plane. The fact that the CBF disagreement between vendors in study 2 was largest in the posterior flow territory could be attributed to the fact that vertebral arteries are more tortuous than carotid arteries, increasing the possibility for a less perpendicular intersection of the vertebral arteries by the labeling plane 11 . This could also explain the higher wsCV and lower qualitative similarity rates in the posterior flow territory.
It should be acknowledged that the main strength of this study is at the same time also its main weakness. The study design was optimized for an optimal similarity of pulse sequences between vendors within the same study, and not for optimal ASL SNR across all three scanners. This included the disabling of imaging enhancement features such as background suppression, parallel acceleration, partial
Fourier and geometric distortion filters. These features were disabled to narrow down possible origins of inter-vendor variability, to achieve a more valid basis for comparison. Although the SNR penalty by disabling the image enhancement features were counterbalanced by longer scanning as well as scanning healthy young volunteers, the results of the current study may deviate from normal clinical or research practice. These enhancement features may reduce the intra-scanner variability because of increased SNR, but may increase the inter-vendor variability because they are implementations that may vary between vendors 17 . Therefore, it remains unknown to what extent these features can affect the multi-center reproducibility of ASL. Still, the sequence as validated in this study could serve as a benchmark to compare other, more optimal, sequences between scanners from different vendors.
Another limitation of the current study is the use of 2D sequences, whereas 3D sequences have recently been proposed as the recommended standard 10 . The practical reason for choosing a 2D readout was that the implementation and reconstruction of identical 3D sequences on all vendors was not deemed feasible at the initiation of this study. When similar implementations of 3D sequences would be available on all vendors, both the intra-and inter-vendor variability could be expected to be lower because of the relatively higher SNR of 3D readouts. Especially because of the optimal performance of background suppression for 3D readouts, which greatly improves the reproducibility of ASL 10, 17 . However, it remains unclear whether spatial correlation and blurring differences are smaller or larger between different 3D readouts than between 2D and 3D readouts 17 .
Conclusion
Using near-identical ASL sequences, this multi-vendor study demonstrates the possibility to acquire comparable cerebral CBF maps on scanners from different vendors. Small differences in sequence parameters can have a larger effect on the reproducibility of ASL than hardware or software differences between vendors. These results stress the importance of using identical labeling and readout strategies when perfusion maps from multiple MRI scanners are pooled. Future efforts towards harmonization of pulse sequence approaches between vendors should pave the way for multi-center clinical perfusion studies. Table 4 . Inter-session within-subject coefficient of variation (wsCV) (confidence intervals), shown in percentages (%). Ratio represents the inter-/ intra-vendor SDΔCBF-ratio. The study 1/study 2 SDΔCBF-ratio for vendor A is shown in the last column. CI = confidence interval. *p<0.05, †p<0.001 Figure 4 . within-subject coefficient of variability (wsCV)-maps of study 1 (a-c) and study 2 (d-f) projected on mean gray matter (GM) probability maps; g) GM wsCV histograms Figure 6 . Variation ratio. a,c) ratio of inter-over intra-vendor standard deviation of paired inter-session differences (SDΔCBF) and b,d) binary maps projected on mean gray matter (GM) probability maps, indicating for which voxels the variation ratio is significantly different from 100%. e) gray matter variation ratio histograms. 
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